American Biogenetic Sciences, Inc. - Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Cash flows from operating activities:
Net loss	$ (24,473)	$ (20,117)
Adjustments to reconcile net loss to cash used in operating activities:
Fair value of services provided by related parties	0	10,000
(Increase) decrease in current assets
Increase (decrease) in accounts payable and accrued expenses	1,566	2,117
Cash flows used by operating activities	(22,907)	(8,000)
Cash flows from investing activities:
Cash used in investing activities	0	0
Cash flows from financing activities:
Procceds from related party borrowings	22,907	8,000
Cash generated by financing activities	22,907	8,000
Change in cash	$ 0	$ 0
Cash - beginning of period	0	0
Cash - end of period	0	0